Related resources and publications
Therapeutic efficacy and pharmacokinetics
Physiological relevancy in preclinical models
Humanized ICP in immuno-oncology
Immuno-oncolology models
Immuno-oncolology models
Immuno-oncolology models
Humanized mouse models
T-cell engager
Assess toxicity with ICP
T-cell engager
Humanized PD-1 & GITR mouse
T-cell engager CD3
Assess T-cell engager in BRGSF-HIS
Humanized PD-1/PD-L1 mouse and cell line
Humanized HSA/hFcRn mouse
Humanized ICP mouse and cell lines
Hear Res
Cell Mol Life Sci
Front Immunol
J Allergy Clin Immunol
Proc Natl Acad Sci U S A
Immunohorizons
PLoS One
J Thromb Haemost
Pancreatology
Acta Biomater
Matrix Biol
Front Immunol
J Invest Dermatol
J Allergy Clin Immunol
Int J Pharmac
J Immunother Cancer
Prog Neurobiol
Nat Cancer
Cell Rep
Sci Rep
Mol Cancer
Neurobiol Dis
ACS Pharmacol Transl Sci
Nat Med
Cell Death Dis
Matrix Biol
Bioconjug Chem
Proc Natl Acad Sci U S A
Cancer Discov
J Bone Miner Res
Nat Chem Biol
Cell
Nat Chem Biol
J Immunother Cancer
Sci Adv
Hum Genet
Eur J Microbiol Immunol
J Alzheimers Dis
Cell Physiol Biochem
Invest Ophthalmol Vis Sci
JCI Insight
PLoS One
EMBO J
Circ Res
Brain
PLoS One
J Biol Chem
J Am Heart Assoc
J Control Release
Arterioscler Thromb Vasc Biol
Physiol Rep
Blood
J Bone Miner Res
J Neurosci
Cell Death Differ
Cell Mol Life Sci
Diabetes
BRGSF-HIS & hFcγR to assess cell depletion
CD3 and BRGSF-HIS to assess IrAEs